Post by account_disabled on Mar 11, 2024 19:16:29 GMT -8
A year ago I wrote an article titled Ten Good News About Coronavirus . The objective was to show that science, knowledge and cooperation are essential to fight the pandemic. We do not know what will happen in the coming months and the new genetic variants are a cause of uncertainty, but a year later the message is the same: advances in science encourage us to be optimistic and see the glass half full. 1. There are more articles about SARS-CoV-2 and covid-19 than about malaria A year ago we were amazed that in just over a month since the first cases were reported, there were already more than 164 scientific articles in PubMed about the new virus and the disease. Today that figure has multiplied by more than 600 and now exceeds 100,000 articles, more than those that appear under the heading “malaria,” for example.
There are more than 4,800 ongoing studies on treatments and vaccines. We know more about SARS-CoV-2 and covid-19 than about other diseases that we have been studying for decades. 2. More than 200 new vaccines A year ago it was noted that there were eight new projects on vaccines Belgium Mobile Number List against the SARS-CoV-2 coronavirus. According to the bioRENDER portal there are now more than 195 candidates, at least already in clinical trials. These employ all types of technologies: live attenuated viruses, inactivated viruses, protein subunits, recombinant viral vectors, virus-like particles (VLPs), DNA and mRNA. Never before had so much money been invested and there had been so much collaboration for the development of vaccines between public and private entities, research centers, universities, pharmaceutical companies, companies and.
Some projects have been abandoned, but others are already authorized by the WHO: Pfizer/BioNTech and Moderna with mRNA technology, AstraZeneca/Oxford and Sputnik V with recombinant adenovirus technology and the Chinese Sinopharma, with inactive coronaviruses. At least 20 other vaccines are already in phase III clinical trials and in the coming weeks and months they may be approved, if the results are satisfactory. 3. mRNA vaccines are very safe One of the possible serious effects of vaccines is anaphylaxis, an allergic reaction that can be fatal and that usually occurs shortly after administering the vaccine. Data from the first month of vaccination in the US have been analyzed, where more than.
There are more than 4,800 ongoing studies on treatments and vaccines. We know more about SARS-CoV-2 and covid-19 than about other diseases that we have been studying for decades. 2. More than 200 new vaccines A year ago it was noted that there were eight new projects on vaccines Belgium Mobile Number List against the SARS-CoV-2 coronavirus. According to the bioRENDER portal there are now more than 195 candidates, at least already in clinical trials. These employ all types of technologies: live attenuated viruses, inactivated viruses, protein subunits, recombinant viral vectors, virus-like particles (VLPs), DNA and mRNA. Never before had so much money been invested and there had been so much collaboration for the development of vaccines between public and private entities, research centers, universities, pharmaceutical companies, companies and.
Some projects have been abandoned, but others are already authorized by the WHO: Pfizer/BioNTech and Moderna with mRNA technology, AstraZeneca/Oxford and Sputnik V with recombinant adenovirus technology and the Chinese Sinopharma, with inactive coronaviruses. At least 20 other vaccines are already in phase III clinical trials and in the coming weeks and months they may be approved, if the results are satisfactory. 3. mRNA vaccines are very safe One of the possible serious effects of vaccines is anaphylaxis, an allergic reaction that can be fatal and that usually occurs shortly after administering the vaccine. Data from the first month of vaccination in the US have been analyzed, where more than.